Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
about
Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancerChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR2: a target for pancreatic cancer treatment?The CXCL8-CXCR1/2 pathways in cancerCXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasisA multi-targeted approach to suppress tumor-promoting inflammationLow level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell modelConstitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerBreast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureOpposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.Low vitamin D status is associated with inflammation in patients with prostate cancerCombined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.The role of chemoattractant receptors in shaping the tumor microenvironment.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionPotentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissueA combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.P2X7 mediates ATP-driven invasiveness in prostate cancer cells.A high-fat diet containing lard accelerates prostate cancer progression and reduces survival rate in mice: possible contribution of adipose tissue-derived cytokinesThe expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancerEpigenetically altered miR-193b targets cyclin D1 in prostate cancerInducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.Gene variants in the angiogenesis pathway and prostate cancer.Role of chemokines in tumor growth.Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.Mitogenic effects of interleukin-8/CXCL8 on cancer cells.CXCL5 promotes prostate cancer progressionClinical utilization of chemokines to combat cancer: the double-edged sword.Periprostatic adipocytes act as a driving force for prostate cancer progression in obesityCXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significanceCXC chemokines and prostate cancer: growth regulators and potential biomarkers.Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation.Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor.Epithelial morphogenesis of MDCK cells in three-dimensional collagen culture is modulated by interleukin-8.Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
P2860
Q21136183-6B534DA0-57F9-4AB6-9072-C815AD808A98Q26866236-84B349DC-CDE5-4726-8E0F-D0E7851C94FBQ27021588-28649FB8-2C7A-4009-800B-BB62DD017106Q28075994-EBF2F5E3-F2B7-45E6-B93D-2ED0559A9321Q28304012-F5AF522C-46D6-48AD-86B0-D21251CF2B53Q28393278-58555FE2-43C9-46B3-8647-55E41F9B830BQ28394495-49C06449-266A-4128-A70B-621005E7EA07Q28483606-3F4697A9-C6BA-43C7-9657-8A9846BB916BQ29622952-7274AAAD-865D-425D-A049-24191A84DBF9Q30439835-51D79BBE-4F13-4939-BA4D-49CF94A8A6A8Q31130674-17143577-69D0-41BA-A583-DEF7E9CF8987Q33591811-C541311E-2A9B-46CE-96EE-233D8A38F6E3Q33602017-5D66F47F-544C-423C-A0EF-BE1629C4BF6CQ33751266-DFAF6A1A-4F40-4315-9D25-3DA552C0B29FQ33993124-669A35EA-6353-4931-A984-4C092313793DQ34090617-BD5F9FAA-3CB6-4352-8F16-C4BC22E81D93Q34289623-C413FA9F-E436-4F61-832E-4D87945DE30FQ34627786-60BCFE5C-B6FF-4C02-95E4-4CEF47023BC6Q35498775-6844130E-6691-4F22-95E6-B2D10A591DABQ35498810-EA51C5ED-4BB2-4029-960B-1D7FA2C56EBBQ35500124-98F5FBC4-4B50-41B3-AA29-66D2B2070EE4Q35585932-07AB551C-80D3-4269-B983-6126D540FF42Q35754593-75DC645C-1215-4FDE-A086-C54F2898D5DDQ36051801-28D9EE67-659D-4DBB-B566-277B740357ECQ36084010-D5A03550-8A58-456D-81C9-CEFAEF056787Q36118876-E56642DE-0680-4A6A-BB9E-6F36CF010C72Q36120825-DE6B5A2B-E1E3-4FCC-B370-8FB226EF252EQ36190681-6605C12C-0C89-4B84-8A39-D9E6BB799F59Q36379310-ED607CCA-8019-4510-9EB7-39262B844A50Q36429600-BFBCAA52-8C55-49D3-A1E6-53F7CD9DE888Q36487549-B201EA38-153C-4D35-901D-C1D88C264106Q36488894-4B6522DD-EBBF-4211-8902-15F061660801Q36511320-2C6A115E-772E-494A-A3FC-EAECB5E04A61Q36544886-00B90715-05F0-4EA7-AB54-E38806AEBA55Q36611793-7E511573-9270-460A-A8CC-939D800E9CE9Q36616524-607522F4-D71C-4C50-9EF0-E39CCC97DEC8Q36659495-DA61FDCC-8E96-41B2-B3B6-E246D808CEA8Q36725395-5D81E3D9-08F2-4459-AD7E-AC0C08257FECQ36836281-5928BFEB-B6D1-40BD-B553-BF8B96A50F2BQ36882649-65160B47-7E7B-4CC7-B961-C62EAEC8596A
P2860
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nonapical and cytoplasmic expr ...... el density in prostate cancer.
@en
type
label
Nonapical and cytoplasmic expr ...... el density in prostate cancer.
@en
prefLabel
Nonapical and cytoplasmic expr ...... el density in prostate cancer.
@en
P2093
P1476
Nonapical and cytoplasmic expr ...... el density in prostate cancer.
@en
P2093
Alfredo Santinelli
Catherine Murphy
David J J Waugh
Johanna Pettigrew
Maryalice McGurk
Patrick G Johnston
Roberta Mazzucchelli
P304
P356
10.1158/1078-0432.CCR-04-1518
P407
P577
2005-06-01T00:00:00Z